Loading…
A Case of Autoimmune Encephalitis with Refractory Status Epilepticus
Refractory status epilepticus is usually caused by a severe brain injury and has a high rate of mortality and morbidity despite the infusion of antiepileptic drugs and anesthetic agents. Autoimmune encephalitis is one cause of refractory status epilepticus and status epilepticus may be the initial s...
Saved in:
Published in: | Archives of Epilepsy 2019-01, Vol.25 (3), p.165-168 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 168 |
container_issue | 3 |
container_start_page | 165 |
container_title | Archives of Epilepsy |
container_volume | 25 |
creator | Merve Melodi ÇAKAR Aslıhan AKŞAR Meliha AKPINAR Elif MERCAN Sezgin KEHAYA Babürhan GÜLDİKEN |
description | Refractory status epilepticus is usually caused by a severe brain injury and has a high rate of mortality and morbidity despite the infusion of antiepileptic drugs and anesthetic agents. Autoimmune encephalitis is one cause of refractory status epilepticus and status epilepticus may be the initial symptom. The seizures are generally resistant to standard treatment and may require immunotherapeutics. This is a description of a patient who had refractory status epilepticus despite appropriate doses of antiepileptic and general anesthetic drugs, but responded to intravenous immunoglobulin therapy. Examinations revealed an ovarian teratoma with a negative serum N-methyl-D-aspartate receptor antibody. |
doi_str_mv | 10.14744/epilepsi.2019.91259 |
format | article |
fullrecord | <record><control><sourceid>doaj</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_d2a77112403d4ead9701a3b7fa80129b</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_d2a77112403d4ead9701a3b7fa80129b</doaj_id><sourcerecordid>oai_doaj_org_article_d2a77112403d4ead9701a3b7fa80129b</sourcerecordid><originalsourceid>FETCH-LOGICAL-c242t-6715b7248a07a02636336b54a95fcc49f31d390246758876f4549d00abc7057e3</originalsourceid><addsrcrecordid>eNotjstqwzAQRUWh0JDmD7rQDzgdjSTLWoY0bQOBQh9rM5alRsGJjSVT8vctaVYXzuKcy9iDgKVQRqlHP8TODykuEYRdWoHa3rAZGosFaA13bJHSAQDQojTCztjTiq8ped4HvppyH4_H6eT55uT8sKcu5pj4T8x7_u7DSC7345l_ZMpT4ptLKkc3pXt2G6hLfnHdOft63nyuX4vd28t2vdoVDhXmojRCNwZVRWAIsJSllGWjFVkdnFM2SNFKC6hKo6vKlEFpZVsAapwBbbycs-2_t-3pUA9jPNJ4rnuK9QX043dN49-jztctkjFCoALZKk-tNSBINiZQBQJtI38BZrlZHQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A Case of Autoimmune Encephalitis with Refractory Status Epilepticus</title><source>DOAJ Directory of Open Access Journals</source><creator>Merve Melodi ÇAKAR ; Aslıhan AKŞAR ; Meliha AKPINAR ; Elif MERCAN ; Sezgin KEHAYA ; Babürhan GÜLDİKEN</creator><creatorcontrib>Merve Melodi ÇAKAR ; Aslıhan AKŞAR ; Meliha AKPINAR ; Elif MERCAN ; Sezgin KEHAYA ; Babürhan GÜLDİKEN</creatorcontrib><description>Refractory status epilepticus is usually caused by a severe brain injury and has a high rate of mortality and morbidity despite the infusion of antiepileptic drugs and anesthetic agents. Autoimmune encephalitis is one cause of refractory status epilepticus and status epilepticus may be the initial symptom. The seizures are generally resistant to standard treatment and may require immunotherapeutics. This is a description of a patient who had refractory status epilepticus despite appropriate doses of antiepileptic and general anesthetic drugs, but responded to intravenous immunoglobulin therapy. Examinations revealed an ovarian teratoma with a negative serum N-methyl-D-aspartate receptor antibody.</description><identifier>EISSN: 2792-0550</identifier><identifier>DOI: 10.14744/epilepsi.2019.91259</identifier><language>eng</language><publisher>Galenos Yayinevi</publisher><subject>immunotherapy ; intravenous immunoglobulin ; pareneoplastic limbic encephalitis ; status epilepticus</subject><ispartof>Archives of Epilepsy, 2019-01, Vol.25 (3), p.165-168</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,2095,27903,27904</link.rule.ids></links><search><creatorcontrib>Merve Melodi ÇAKAR</creatorcontrib><creatorcontrib>Aslıhan AKŞAR</creatorcontrib><creatorcontrib>Meliha AKPINAR</creatorcontrib><creatorcontrib>Elif MERCAN</creatorcontrib><creatorcontrib>Sezgin KEHAYA</creatorcontrib><creatorcontrib>Babürhan GÜLDİKEN</creatorcontrib><title>A Case of Autoimmune Encephalitis with Refractory Status Epilepticus</title><title>Archives of Epilepsy</title><description>Refractory status epilepticus is usually caused by a severe brain injury and has a high rate of mortality and morbidity despite the infusion of antiepileptic drugs and anesthetic agents. Autoimmune encephalitis is one cause of refractory status epilepticus and status epilepticus may be the initial symptom. The seizures are generally resistant to standard treatment and may require immunotherapeutics. This is a description of a patient who had refractory status epilepticus despite appropriate doses of antiepileptic and general anesthetic drugs, but responded to intravenous immunoglobulin therapy. Examinations revealed an ovarian teratoma with a negative serum N-methyl-D-aspartate receptor antibody.</description><subject>immunotherapy</subject><subject>intravenous immunoglobulin</subject><subject>pareneoplastic limbic encephalitis</subject><subject>status epilepticus</subject><issn>2792-0550</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNotjstqwzAQRUWh0JDmD7rQDzgdjSTLWoY0bQOBQh9rM5alRsGJjSVT8vctaVYXzuKcy9iDgKVQRqlHP8TODykuEYRdWoHa3rAZGosFaA13bJHSAQDQojTCztjTiq8ped4HvppyH4_H6eT55uT8sKcu5pj4T8x7_u7DSC7345l_ZMpT4ptLKkc3pXt2G6hLfnHdOft63nyuX4vd28t2vdoVDhXmojRCNwZVRWAIsJSllGWjFVkdnFM2SNFKC6hKo6vKlEFpZVsAapwBbbycs-2_t-3pUA9jPNJ4rnuK9QX043dN49-jztctkjFCoALZKk-tNSBINiZQBQJtI38BZrlZHQ</recordid><startdate>20190101</startdate><enddate>20190101</enddate><creator>Merve Melodi ÇAKAR</creator><creator>Aslıhan AKŞAR</creator><creator>Meliha AKPINAR</creator><creator>Elif MERCAN</creator><creator>Sezgin KEHAYA</creator><creator>Babürhan GÜLDİKEN</creator><general>Galenos Yayinevi</general><scope>DOA</scope></search><sort><creationdate>20190101</creationdate><title>A Case of Autoimmune Encephalitis with Refractory Status Epilepticus</title><author>Merve Melodi ÇAKAR ; Aslıhan AKŞAR ; Meliha AKPINAR ; Elif MERCAN ; Sezgin KEHAYA ; Babürhan GÜLDİKEN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c242t-6715b7248a07a02636336b54a95fcc49f31d390246758876f4549d00abc7057e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>immunotherapy</topic><topic>intravenous immunoglobulin</topic><topic>pareneoplastic limbic encephalitis</topic><topic>status epilepticus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Merve Melodi ÇAKAR</creatorcontrib><creatorcontrib>Aslıhan AKŞAR</creatorcontrib><creatorcontrib>Meliha AKPINAR</creatorcontrib><creatorcontrib>Elif MERCAN</creatorcontrib><creatorcontrib>Sezgin KEHAYA</creatorcontrib><creatorcontrib>Babürhan GÜLDİKEN</creatorcontrib><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Archives of Epilepsy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Merve Melodi ÇAKAR</au><au>Aslıhan AKŞAR</au><au>Meliha AKPINAR</au><au>Elif MERCAN</au><au>Sezgin KEHAYA</au><au>Babürhan GÜLDİKEN</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Case of Autoimmune Encephalitis with Refractory Status Epilepticus</atitle><jtitle>Archives of Epilepsy</jtitle><date>2019-01-01</date><risdate>2019</risdate><volume>25</volume><issue>3</issue><spage>165</spage><epage>168</epage><pages>165-168</pages><eissn>2792-0550</eissn><abstract>Refractory status epilepticus is usually caused by a severe brain injury and has a high rate of mortality and morbidity despite the infusion of antiepileptic drugs and anesthetic agents. Autoimmune encephalitis is one cause of refractory status epilepticus and status epilepticus may be the initial symptom. The seizures are generally resistant to standard treatment and may require immunotherapeutics. This is a description of a patient who had refractory status epilepticus despite appropriate doses of antiepileptic and general anesthetic drugs, but responded to intravenous immunoglobulin therapy. Examinations revealed an ovarian teratoma with a negative serum N-methyl-D-aspartate receptor antibody.</abstract><pub>Galenos Yayinevi</pub><doi>10.14744/epilepsi.2019.91259</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | EISSN: 2792-0550 |
ispartof | Archives of Epilepsy, 2019-01, Vol.25 (3), p.165-168 |
issn | 2792-0550 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_d2a77112403d4ead9701a3b7fa80129b |
source | DOAJ Directory of Open Access Journals |
subjects | immunotherapy intravenous immunoglobulin pareneoplastic limbic encephalitis status epilepticus |
title | A Case of Autoimmune Encephalitis with Refractory Status Epilepticus |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T20%3A46%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-doaj&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Case%20of%20Autoimmune%20Encephalitis%20with%20Refractory%20Status%20Epilepticus&rft.jtitle=Archives%20of%20Epilepsy&rft.au=Merve%20Melodi%20%C3%87AKAR&rft.date=2019-01-01&rft.volume=25&rft.issue=3&rft.spage=165&rft.epage=168&rft.pages=165-168&rft.eissn=2792-0550&rft_id=info:doi/10.14744/epilepsi.2019.91259&rft_dat=%3Cdoaj%3Eoai_doaj_org_article_d2a77112403d4ead9701a3b7fa80129b%3C/doaj%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c242t-6715b7248a07a02636336b54a95fcc49f31d390246758876f4549d00abc7057e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |